<DOC>
	<DOCNO>NCT01561664</DOCNO>
	<brief_summary>Insulin resistance one main mechanism involve metabolic disease . inflammation implicate pathogenesis , due innate immunity activation free fatty acid , lipopolysaccharides ( LPS ) lactate . Free fatty acid , LPS lactate activate innate immunity squelettal muscle adipose tissue via Toll-like receptor 2/4 , NFkB , IRF3 ( Interferon Responsive Factor 3 ) cytokine secretion ( TNFa , IFN g , IL1b , IL6 ) , chemokines secretion ( MCP1 ) leukotrienes ( LTB4 ) . Feed back mechanisms involve TLR signal pathway RLI ( ribonuclease L inhibitor ) /ABCE1 , never study inflammation due obesity . RLI inhibit endoribonuclease , RNase L , recently implicate TLR signal The purpose study analyse role RLI RNase L TLR regulation , potential implication link obesity , inflammation insulin resistance adipose tissue squeletal muscle human .</brief_summary>
	<brief_title>Inflammation Regulation Obese Patients</brief_title>
	<detailed_description>The investigator work hypothesis RNase L RLI contribute chronic inflammation regulation insulin response TLR 4 pathway regulation obesity . The investigator main purpose compare innate immunity activation pathway insulin sensitive , insulin resistant obese patient control patient . Insulin sensitive insulin resistant obese patient distinguish thanks HOMA ir index . The investigator second objective evaluate degree inflammation adipose tissue squeletal muscle correlate insulin sensitivity measure hyperinsulinemic euglycemic clamp characterise inflammatory pathway regulation pathway . A special focus give leukotrienes potential role insulin resistance pathogenesis . The investigator two approach : - characterisation subject normal weight , obese insulin sensitive obese insulin resistant metabolic evaluation , inflammatory characterisation measure insulin sensitivity systemic level , adipose tissue squeletal muscle.- vitron approach human myoblast adipocytes culture , extract investigator patient : characterisation inflammation , innate immunity .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 50 65 year old Men/ menopausal woman BMI &lt; 25 kg/m2 control group , BMI &gt; 30 kg/m2 obese group Non diabetic patient HOMAIR &lt; 3 insulin sensitive obese group Non smoking Without inflammatory disease Without first degree relative diabetes Without treatment could interfere insulin sensitivity without infection</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>obesity</keyword>
	<keyword>insulin resistance</keyword>
</DOC>